Home > Healthcare > Biotechnology > Bioservices > Spatial Genomics and Transcriptomics Market

Spatial Genomics and Transcriptomics Market Share

Report ID: GMI5968
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Spatial Genomics and Transcriptomics Market Share

Some of the major market players operating in the spatial genomics and transcriptomics market are :

Natera Inc.
10x Genomics
Dovetail Genomics
Illumina, Inc.
S2 Genomics, Inc.
NanoString Technologies, Inc.
Seven Bridges Genomics
Horizon Discovery Group plc
CARTANA AB
READCOOR, INC.
Bio-Techne Corporation
Bio-Rad Laboratories, Inc.
Danahar Corporation
BioSpyder Technologies Inc.
Lunaphore Technologies SA.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global market for spatial genomics and transcriptomics was worth over USD 305.5 million in 2022 and is projected to record over 15% CAGR through 2032, owing to increasing research focus on spatial biology, growing demand for deeper insights into cellular function & organization, and advances in sequencing technologies.

The translational research segment will grow at more than 18% CAGR between 2023 to 2032, as the application aims to bridge the gap between basic research discoveries and their practicality in clinical settings. Translation research highlights the potential clinical relevance and utility of spatial genomics and transcriptomics technologies.

North America spatial genomics and transcriptomics market will register a growth rate of over 15% during 2023-2032, on account of a robust R&D landscape in the region, along with a high concentration of pharmaceutical & biotechnology companies, academic institutions, and research organizations.

Natera Inc., 10x Genomics, Dovetail Genomics, Illumina, Inc., S2 Genomics, Inc., NanoString Technologies, Inc., Seven Bridges Genomics, Horizon Discovery Group plc, CARTANA AB, READCOOR, INC., Bio-Techne Corporation, and Bio-Rad Laboratories, Inc. among others.